SEARCH

SEARCH BY CITATION

References

  • Arbuthnott G. W., Fairbrother I. S. and Butcher S. P. (1990a) Brain microdialysis studies on the control of dopamine release and metabolism in vivo. J. Neurosci. Meth. 34, 7381.
  • Arbuthnott G. W., Fairbrother I. S. and Butcher S. P. (1990b) Dopamine release and metabolism in the rat striatum: an analysis by ‘in vivo’ brain microdialysis. Pharmacol. Ther. 48, 281293.
  • Benabid A. L., Benazzouz A., Hoffmann D., Limousin P., Krack P. and Pollak P. (1998) Long-term electrical inhibition of deep brain targets in movement disorders. Mov. Disord. 13, 119125.
  • Benazzouz A. and Hallett M. (2000) Mechanism of action of deep brain stimulation. Neurology 55, S13S16.
  • Bowyer J. F., Frame L. T., Clausing P., Nagamoto-Combs K., Osterhout C. A., Sterling C. R. and Tank A. W. (1998) Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats. J. Pharmacol. Exp. Ther. 286, 10741085.
  • Bruet N., Windels F., Bertrand A., Feuerstein C., Poupard A. and Savasta M. (2001) High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. J. Neuropathol. Exp. Neurol. 60, 1524.
  • Butcher S. P., Fairbrother I. S., Kelly J. S. and Arbuthnott G. W. (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J. Neurochem. 50, 346355.
  • Butcher S. P., Fairbrother I. S., Kelly J. S. and Arbuthnott G. W. (1990) Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum. J. Neurochem. 55, 981988.
  • Callaway C. W., Kuczenski R. and Segal D. S. (1989) Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine. Brain Res. 505, 8390.
  • Cenci M. A., Kalen P., Mandel R. J. and Bjorklund A. (1992) Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat. Brain Res. 581, 217228.
  • Dahlström A., Fuxe K. and Hillarp N. A. (1965) Site of action of reserpine. Acta Pharmacol. Toxicol. 22, 277292.
  • Diana M., Garcia-Munoz M., Richards J. and Freed C. R. (1989) Electrophysiological analysis of dopamine cells from the substantia nigra pars compacta of circling rats. Exp. Brain Res. 74, 625630.
  • Di Chiara G., Carboni E., Morelli M., Cozzolino A., Tanda G. L., Pinna A., Russi G. and Consolo S. (1993) Stimulation of dopamine transmission in the dorsal caudate nucleus by pargyline as demonstrated by dopamine and acetylcholine microdialysis and Fos immunohistochemistry. Neuroscience 55, 451456.
  • Ehringer H. and Hornykiewicz O. (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wochenschr. 38, 12361239.
  • Elsworth J. D. and Roth R. H. (1997) Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp. Neurol. 144, 49.
  • Elverfors A., Pileblad E., Lagerkvist S., Bergquist F., Jonason J. and Nissbrandt H. (1997) 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra. J. Neurochem. 69, 16841692.
  • Galloway M. P., Wolf M. E. and Roth R. H. (1986) Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J. Pharmacol. Exp. Ther. 236, 689698.
  • Gerhardt G. A. and Maloney R. E. (1999) Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats. Brain Res. 816, 6877.
  • Guldberg H. C. and Broch O. J. (1971) On the mode of action of reserpine on dopamine metabolism in the rat striatum. Eur. J. Pharmacol. 13, 155167.
  • Haycock J. W., Ahn N. G., Cobb M. H. and Krebs E. G. (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Natl Acad. Sci. USA 89, 23652369.
  • Imperato A. and Di Chiara G. (1984) Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci. 4, 966977.
  • Justice J. B., Nicolaysen L. C. and Michael A. C. (1988) Modeling the dopaminergic nerve terminal. J. Neurosci. Meth. 22, 239252.
  • Kannari K., Tanaka H., Maeda T., Tomiyama M., Suda T. and Matsunaga M. (2000) Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation. J. Neurochem. 74, 263269.
  • Krack P., Limousin P., Benabid A. L. and Pollak P. (1997a) Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet 350, 1676.
  • Krack P., Pollak P., Limousin P., Benazzouz A. and Benabid A. L. (1997b) Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 350, 1675.
  • Krack P., Hamel W., Mehdorn H. M. and Deuschl G. (1999) Surgical treatment of Parkinson's disease. Curr. Opin. Neurol. 12, 417425.
  • Krnjevic K., Lamour Y., MacDonald J. F. and Nistri A. (1978) Intracellular actions of monoamine transmitters. Can. J. Physiol. Pharmacol. 56, 896900.
  • Kumer S. C. and Vrana K. E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443462.
  • Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D. and Benabid A. L. (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 339, 11051111.
  • Lindberg R. L. and Syvalahti E. K. (1986) Metabolism of nomifensine after oral and intravenous administration. Clin. Pharmacol. Ther. 39, 378383.
  • Lindgren N., Xu Z. Q., Herrera-Marschitz M., Haycock J., Hokfelt T. and Fisone G. (2001) Dopamine D(2) receptors regulate tyrosine hydroxylase activity and phosphorylation at Ser40 in rat striatum. Eur. J. Neurosci. 13, 773780.
  • Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265275.
  • Marsden C. D., Parkes J. D. and Quinn N. (1982) Fluctuations of disability in Parkinson's disease-clinical aspects, in Neurology 2: Movement Disorders (MarsdenC. D. and FahnS., eds), pp. 96122. Butterworth Scientific, London.
  • Meissner W., Reum T., Paul G., Harnack D., Sohr R., Morgenstern R. and Kupsch A. (2001) Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci. Lett. 303, 165168.
  • Meissner W., Harnack D., Paul G., Reum T., Sohr R., Morgenstern R. and Kupsch A. (2002) Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci. Lett. 328, 105108.
  • Nagatsu T., Oka K. and Kato T. (1979) Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromatogr. 163, 247252.
  • Nakahara D., Fuchikami K., Ozaki N., Iwasaki T. and Nagatsu T. (1992) Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis. Brain Res. 574, 164170.
  • Naoi M., Takahashi T. and Nagatsu T. (1988) Simple assay procedure for tyrosine hydroxylase activity by high-performance liquid chromatography employing coulometric detection with minimal sample preparation. J. Chromatogr. 427, 229238.
  • Panova N. G., Axenova L. N. and Medvedev A. E. (2000) The stimulating effects of ethanol consumption on synthesis of rat brain monoamine oxidases and their sensitivity to the irreversible inhibitor, pargyline. Neurosci. Lett. 292, 6668.
  • Paul G., Reum T., Meissner W., Marburger A., Sohr R., Morgenstern R. and Kupsch A. (2000) High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport 11, 441444.
  • Paxinos W. and Watson C. (1997) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
  • Planz G., Quiring K. and Palm D. (1972) Rates of recovery of irreversibly inhibited monoamine oxidases: a measure of enzyme protein turnover. Naunyn Schmiedebergs Arch. Pharmacol. 273, 2742.
  • Roth R. H., Murrin L. C. and Walters J. R. (1976) Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur. J. Pharmacol. 36, 163171.
  • Sabol K. E., Richards J. B. and Freed C. R. (1990) In vivo dialysis measurements of dopamine and DOPAC in rats trained to turn on a circular treadmill. Pharmacol. Biochem. Behav. 36, 2128.
  • Segal D. S. and Kuczenski R. (1974) Tyrosine hydroxylase activity: regional and subcellular distribution in the brain. Brain Res. 68, 261266.
  • Tokuyama W., Hashimoto T., Li Y. X., Okuno H. and Miyashita Y. (1999) Quantification of neurotrophin-3 mRNA in the rat hippocampal subregions using the RT-PCR-based coamplification method. Brain Res. Brain Res. Protoc. 4, 407414.
  • Waldmeier P. C. and Maitre L. (1976) Comparison of short and long-lasting effects of pargyline on cerebral dopamine metabolism. Naunyn Schmiedebergs Arch. Pharmacol. 294, 133140.
  • Wong P. T., Teo W. L. and Lee T. (1993) A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine. Neuroreport 5, 5356.
  • Yahr M. D., Duvoisin R. C., Schear M. J., Barrett R. E. and Hoehn M. M. (1969) Treatment of parkinsonism with levodopa. Arch. Neurol. 21, 343354.
  • Zetterström T., Sharp T., Marsden C. A. and Ungerstedt U. (1983) In vivo measurement of dopamine and its metabolites by intracerebral dialysis: changes after d-amphetamine. J. Neurochem. 41, 17691773.
  • Zetterström T., Sharp T., Collin A. K. and Ungerstedt U. (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs; implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327334.